Cart
sales@molnova.com
Home - Products - Others - Other Targets - TP748

TP748

CAS No. 951698-15-0

TP748( —— )

Catalog No. M25004 CAS No. 951698-15-0

TP748 is a key intermediate for fully synthetic tetracyclines, and is an isoxazole.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 32 In Stock
5MG 28 In Stock
10MG 40 In Stock
25MG 65 In Stock
50MG 91 In Stock
100MG 137 In Stock
200MG 203 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    TP748
  • Note
    Research use only, not for human use.
  • Brief Description
    TP748 is a key intermediate for fully synthetic tetracyclines, and is an isoxazole.
  • Description
    TP748 is a key intermediate for fully synthetic tetracyclines, and is an isoxazole.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    951698-15-0
  • Formula Weight
    258.32
  • Molecular Formula
    C15H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CN(C)[C@@H](C=C)c1cc(OCc2ccccc2)no1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wu-Yan Zhang, et al. Process Research and Development of TP-808: A Key Intermediate for the Manufacture of Synthetic Tetracyclines. Process Res. Dev. 2017, 21, 3, 377-386.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • BDA 366

    BDA-366 specifically targets the BH4 domain of Bcl2 BDA-366 and suppresses human myeloma growth. BDA-366 induces robust apoptosis in MM cell lines and primary MM cells by inducing BCL2 conformational change.

  • Syk Inhibitor II hyd...

    The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.

  • Gamma-Methylleucine

    Gamma-Methylleucine is an auxiliary for copper-catalyzed asymmetric Michael reactions.

Sign In Join Free